Recently, PTK7 was found to be overexpressed in various human cancers, including epithelial tumors such as gastric, breast, esophagus, biliary duct and lung cancers [21–26] but also in sarcoma [27] and in hematological malignancies, including acute and chronic myeloid leukemias [28–30]. Here, PTK7 is linked to lung carcinoma.